AGT and cardiac hypertrophy: This leads to a reduction in the degradation of angiotensin II to cardioprotective angiotensin 1–7 (Ang1–7), with an end effect that induces cardiac hypertrophy, vasoconstriction, tissue fibrosis and increased oxidative stress [34].